ESC 2022 Late-breaker Discussion: The REVIVED Trial

Watch on Radcliffe Cardiology: www.icrjournal.com/video-inde...
Late-breaker host, Dr Harriette Van Spall ((McMaster University, CA) sat down withProf Divaka Perera (Guy's & St Thomas' NHS Foundation Trust) joins us to discuss the findings of the REVIVED trial (NCT01920048).
The rationale of the REVIVED study was to evaluate whether percutaneous coronary intervention (PCI) combined with optical medical therapy would improve survival and reduce hospitalisation in patients with heart failure, as compared to optical medical therapy alone.
Recorded onsite at ESC Congress 22, Barcelona.
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

[@RaBu-ny2ur]

Excellent synopsis of the trial . Thank you.

[@muhammadshahid3971]

Was there any difference on chest pain symptom